formamide has been researched along with chiniofon in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, SH; Cheng, JP; Xiao, ZY; Yang, RF; Yun, LH; Zhang, YX; Zhou, WX | 1 |
1 other study(ies) available for formamide and chiniofon
Article | Year |
---|---|
Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
Topics: Administration, Oral; Adoptive Transfer; Animals; Autoantibodies; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Female; Forkhead Transcription Factors; Formamides; Glomerulonephritis; Graft vs Host Disease; Hydroxyquinolines; Interleukin-10; Interleukin-2 Receptor alpha Subunit; Kidney; Lupus Erythematosus, Systemic; Mice, Inbred CBA; Mice, Inbred DBA; Mice, Inbred MRL lpr; Molecular Structure; Proteinuria; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1 | 2012 |